An Integrated Digital PROM-platform for Cancer Patients During the COVID-19 Pandemic

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

August 3, 2020

Primary Completion Date

February 1, 2021

Study Completion Date

March 22, 2021

Conditions
Covid19OncologyPROMsChemotherapeutic Toxicity
Interventions
OTHER

ePROMs assessment

"At inclusion the patient received a unique login code which he/she used to start the care path. After signing the informed consent on the digital pathway, the patient needed to fill in the questionnaires that were presented at fixed time points throughout this study.~Based on the data collected from the questionnaires the patient received customized information and advice. In case of COVID-19, the information and advice was based on the guidelines from Sciensano and the Belgian government. If the patient suffered from side effects from the cancer therapy, they received tips and tricks how to manage these complications. The collected data was forwarded to the patient medical file. As such health care workers were be able to use this information in the patients' follow up consultations."

Trial Locations (2)

3500

Hasselt University, Hasselt

Jessa Ziekenhuis, Hasselt

All Listed Sponsors
collaborator

Hasselt University

OTHER

lead

Jessa Hospital

OTHER

NCT04816656 - An Integrated Digital PROM-platform for Cancer Patients During the COVID-19 Pandemic | Biotech Hunter | Biotech Hunter